Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/24/2026 | Q4 | -- | -- | -- | -$0.47 | -- |
| 11/13/2025 | Q3 | -- | -- | -$0.48 | -$0.40 | -$0.08 |
| 08/12/2025 | Q2 | -- | -- | -$0.35 | -$0.48 | $0.13 |
| 05/13/2025 | Q1 | -- | -- | -$0.38 | -$0.57 | $0.19 |
| 03/31/2025 | Q4 | -- | -- | -$2.23 | -$0.42 | -$1.81 |
| 11/08/2024 | Q3 | -- | -- | -$0.37 | -$1.17 | $0.80 |
| 08/09/2024 | Q2 | -- | -- | -$0.49 | -$0.47 | -$0.02 |
| 05/09/2024 | Q1 | -- | -- | -$0.51 | -$0.85 | $0.34 |
| 03/28/2024 | Q4 | -- | -- | -$0.61 | -$0.85 | $0.24 |
| 11/09/2023 | Q3 | -- | -- | -$0.69 | -- | -- |
| 08/11/2023 | Q2 | -- | -- | -$0.82 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.93 | -- | -- |
| 03/23/2023 | Q4 | -- | -- | -$1.12 | -- | -- |
| 11/10/2022 | Q3 | -- | -- | -$0.94 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$1.09 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$0.97 | -- | -- |
| 03/24/2022 | Q4 | -- | -- | -$1.06 | -- | -- |
| 11/12/2021 | Q3 | -- | -- | -$0.98 | -- | -- |
| 08/12/2021 | Q2 | -- | -- | -$0.83 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$0.78 | -- | -- |
| 03/25/2021 | Q4 | -- | -- | -$0.93 | -- | -- |
| 11/12/2020 | Q3 | -- | -- | -$0.74 | -- | -- |
| 08/06/2020 | Q2 | -- | -- | -$0.68 | -- | -- |
| 05/07/2020 | Q1 | -- | -- | -$0.51 | -- | -- |
| 03/27/2020 | Q4 | -- | -- | -$0.57 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$0.35 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.43 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$0.65 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.42 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$0.30 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$0.39 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$0.41 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$0.34 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$7.03 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$0.28 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.18 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$0.15 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.09 | -- | -- |
Monopar Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
Monopar Therapeutics, Inc. announced earnings per share of -$0.48 which represents a miss of analyst forecast a -$0.40 per share.
Monopar Therapeutics, Inc. reported -- that represents -- per share over the last quarter.
Monopar Therapeutics, Inc.'s earnings are forecast to decrease from -$4.11 per share to -$1.77 per share next year representing a decrease of -59.24%.
Monopar Therapeutics, Inc.'s next earnings date is March 24, 2026.
Signup to receive the latest stock alerts
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Market Cap: $4.5T
P/E Ratio: 63x
Market Cap: $4T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
UniFirst Corp. [UNF] is up 0.77% over the past day.